These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35468995)

  • 1. Efficacy and safety of different drug treatments in patients with spinal-cord injury-related neuropathic pain: a network meta-analysis.
    Mei L; Fengqun M; Zhengyao Z; Mingming F; Qing W; Xiaozhuo L; Dongpo S; Qian H; Tong C
    Spinal Cord; 2022 Nov; 60(11):943-953. PubMed ID: 35468995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
    Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic interventions for treating phantom limb pain.
    Alviar MJ; Hale T; Dungca M
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD006380. PubMed ID: 27737513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury: An Update.
    Mehta S; McIntyre A; Janzen S; Loh E; Teasell R;
    Arch Phys Med Rehabil; 2016 Aug; 97(8):1381-1391.e1. PubMed ID: 26797114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis.
    Wang ZM; Wang ZY; Wei CJ; Jiang YJ
    Medicine (Baltimore); 2020 Jun; 99(25):e20702. PubMed ID: 32569202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
    Han ZA; Song DH; Chung ME
    Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord injury pain: mechanisms and management.
    Finnerup NB; Baastrup C
    Curr Pain Headache Rep; 2012 Jun; 16(3):207-16. PubMed ID: 22392531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury.
    Li G; Lv CA; Tian L; Jin LJ; Sun P; Zhao W
    Medicine (Baltimore); 2017 May; 96(20):e6919. PubMed ID: 28514309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury.
    Lakra C; Cohen H
    J Spinal Cord Med; 2022 Sep; 45(5):651-655. PubMed ID: 33263489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants Are Effective in Decreasing Neuropathic Pain After SCI: A Meta-Analysis.
    Mehta S; Guy S; Lam T; Teasell R; Loh E
    Top Spinal Cord Inj Rehabil; 2015; 21(2):166-73. PubMed ID: 26364286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence for pharmacological treatment of neuropathic pain.
    Finnerup NB; Sindrup SH; Jensen TS
    Pain; 2010 Sep; 150(3):573-581. PubMed ID: 20705215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone for neuropathic pain in adults.
    McNicol ED; Ferguson MC; Schumann R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Sommer C; Welsch P; Klose P; Schaefert R; Petzke F; Häuser W
    Schmerz; 2015 Feb; 29(1):35-46. PubMed ID: 25376548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic interventions for treating phantom limb pain.
    Alviar MJ; Hale T; Dungca M
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006380. PubMed ID: 22161403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of pharmacologic treatments of pain after spinal cord injury.
    Teasell RW; Mehta S; Aubut JA; Foulon B; Wolfe DL; Hsieh JT; Townson AF; Short C;
    Arch Phys Med Rehabil; 2010 May; 91(5):816-31. PubMed ID: 20434623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
    Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Pregabalin in Neuropathic Pain Followed Spinal Cord Injury: A Review and Meta-Analysis of Randomized Controlled Trials.
    Yu X; Liu T; Zhao D; Yang K; Zhang X; Zhang M; Zhang S; Huang W; Wu B; Li J
    Clin J Pain; 2019 Mar; 35(3):272-278. PubMed ID: 30499836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis.
    Tong C; Zhengyao Z; Mei L; Dongpo S; Qian H; Fengqun M
    Pain Ther; 2021 Dec; 10(2):1497-1509. PubMed ID: 34491542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis.
    Kane CM; Mulvey MR; Wright S; Craigs C; Wright JM; Bennett MI
    Palliat Med; 2018 Jan; 32(1):276-286. PubMed ID: 28604172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis.
    Hary V; Schitter S; Martinez V
    Eur J Pain; 2022 May; 26(5):980-990. PubMed ID: 35293078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.